Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RIC8B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | GLUL | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
mRNA | PSMC2 | FIMM | pan-cancer | AAC | 0.46 | 0.007 |
mRNA | TMSB15A | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
mRNA | CCND3 | FIMM | pan-cancer | AAC | -0.63 | 0.007 |
mRNA | OR8B4 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
mRNA | TUBA1A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
mRNA | TTLL7 | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
mRNA | TMEM217 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
mRNA | RNF224 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |